584167 -OEChem-07250805133D 12 12 0 1 0 0 0 0 0999 V2000 86.6630 9.0670 85.3940 O 0 0 0 0 0 0 0 0 0 0 0 0 87.0110 7.2350 81.8070 O 0 0 0 0 0 0 0 0 0 0 0 0 84.2960 8.0390 82.7930 O 0 0 0 0 0 0 0 0 0 0 0 0 88.7580 7.8210 83.6600 O 0 0 0 0 0 0 0 0 0 0 0 0 87.1360 10.9980 84.2330 O 0 0 0 0 0 0 0 0 0 0 0 0 83.5280 9.0380 86.3280 O 0 0 0 0 0 0 0 0 0 0 0 0 86.6660 8.4130 82.5740 C 0 0 1 0 0 0 0 0 0 0 0 0 85.5240 8.0150 83.5110 C 0 0 1 0 0 0 0 0 0 0 0 0 87.9270 8.9180 83.3160 C 0 0 1 0 0 0 0 0 0 0 0 0 85.3850 8.8880 84.7530 C 0 0 1 0 0 0 0 0 0 0 0 0 87.6190 9.7390 84.5690 C 0 0 2 0 0 0 0 0 0 0 0 0 84.5040 8.1490 85.7500 C 0 0 0 0 0 0 0 0 0 0 0 0 1 10 1 0 0 0 0 1 11 1 0 0 0 0 2 7 1 0 0 0 0 3 8 1 0 0 0 0 4 9 1 0 0 0 0 5 11 1 0 0 0 0 6 12 1 0 0 0 0 7 8 1 0 0 0 0 7 9 1 0 0 0 0 8 10 1 0 0 0 0 9 11 1 0 0 0 0 10 12 1 0 0 0 0 M END > 0 > 0 > 584167 > 5 > MMDB > MAN > 29965.10 > PDB Accession Code 1TY5 Structural Basis For Allostery In Integrins And Binding Of Ligand-Mimetic Therapeutics To The Platelet Receptor For Fibrinogen Cell AdhesionIMMUNE SYSTEM Structural Basis For Allostery In Integrins And Binding Of Ligand-Mimetic Therapeutics To The Platelet Receptor For Fibrinogen Crystal Structure; Platelet Integrin Alphaiibbeta3; Fibrinogen Binding; Allostery; Therapeutic Antagonism Mol_id: 1; Molecule: Integrin Alpha-Iib; Chain: A; Fragment: Residues 1-452; Synonym: Platelet Membrane Glycoprotein Iib; Gpalpha Iib; Gpiib; Cd41 Antigen; Engineered: Yes; Mol_id: 2; Molecule: Integrin Beta-3; Chain: B; Fragment: Residues 1-440; Synonym: Platelet Membrane Glycoprotein Iiia; Gpiiia; Cd61 Antigen; Engineered: Yes; Mol_id: 3; Molecule: Monoclonal Antibody 10e5 Light Chain; Chain: L; Fragment: Light Chain Residues 1-214; Mol_id: 4; Molecule: Monoclonal Antibody 10e5 Heavy Chain; Chain: H; Fragment: Heavy Chain Residues 1-219 > MAN > 29965.10 > 29965 > http://www.ncbi.nlm.nih.gov/Structure/MMDB/mmdb.shtml > http://www.ncbi.nlm.nih.gov/Structure/mmdb/mmdbsrv.cgi?uid=29965 > 185698 1 $$$$